EPISODE · Sep 3, 2021 · 31 MIN

Ivermectin

from Critical Care Reviews Podcast · host Rob Mac Sweeney

Prof Alistair Nichol (Dublin & Melbourne) discusses why the REMAP-CAP adaptive platform trial has chosen to investigate ivermectin, given the controversy surrounding this agent.

Episode metadata supplied by the publisher feed · Published Sep 3, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Ivermectin

0:00 31:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Critical Care Reviews Podcast?

This episode is 31 minutes long.

When was this Critical Care Reviews Podcast episode published?

This episode was published on September 3, 2021.

Can I download this Critical Care Reviews Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!